Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Qazi
Arish Qazi, Kobenhavn K DK
| Patent application number | Description | Published |
|---|---|---|
| 20100220907 | Pathology indicating measure related to cartilage structure and automatic quantification thereof - A method for the analysis of three dimensional scan data representing an articular cartilage is provided to extract a quantitative parameter indicative of joint pathology. A measure representative of cartilage homogeneity is derived from this three dimensional image data. The measured value is compared with similar measured values previously established in respect of healthy joints and/or joints characterised by a pathology. | 09-02-2010 |
Arish Qazi, Toronto CA
| Patent application number | Description | Published |
|---|---|---|
| 20100232671 | OPTIMISED REGION OF INTEREST SELECTION - A statistical framework for identifying regions of discrimination between two groups of imaged objects involves determining a weight map defining the regions of discrimination by minimizing the sample size required to discriminate the two groups in a numerical optimization scheme. | 09-16-2010 |
Ghulam Nabi Qazi, Jammu Tawi IN
| Patent application number | Description | Published |
|---|---|---|
| 20090298938 | USE OF SEMI SYNTHETIC ANALOGUES OF BOSWELLIC ACIDS FOR ANTICANCER ACTIVITY - The present invention relates to use of compounds of general formula 1 for anticancerous activity, wherein the said compound being derived semi-synthetically from natural triterpenoic acids known as boswellic acids by the induction of apoptosis thereof cytotoxicity and anti-cancer activity displayed by semi-synthetic analogues of natural triterpenes, known as Boswellic acids. These compounds may be used for the treatment of cancer, alone or in combination with pharmaceutically acceptable or other carriers, displaying cytotoxicity and anti-cancer activity for colon, prostrate, liver, breast, central nervous system (CNS), leukemia and malignancy of other tissues, including ascites and solid tumors. The cancer cell death is mediated by induction of apoptosis and inhibition of cell proliferation at specific doses. | 12-03-2009 |
| 20100303933 | IMMUNOPOTENTIATING COMPOSITION FROM LABISIA PUMILA EXTRACT - The present invention relates to an immunopotentiating composition and to a composition accelerating the production of interferon-[gamma]. More particularly to a process for preparation of water-soluble | 12-02-2010 |
Ghulam Nabi Qazi, Jammu And Kashmir IN
| Patent application number | Description | Published |
|---|---|---|
| 20080292736 | Bioavailability enhancing activity of carum carvi extracts and fractions thereof - The present invention relates to the use of extracts of | 11-27-2008 |
Ghulam Nabi Qazi, Jammu Kashmir IN
| Patent application number | Description | Published |
|---|---|---|
| 20120021077 | SYNERGISTIC HERBAL COMPOSITION FOR TREATMENT OF RHEUMATIC AND MUSCULO-SKELETAL DISORDERS (RMSDS) - The present invention deals with a synergistic herbal composition useful for treatment of rheumatic and musculo-skeletal disorders (RMSDs) comprising a base formulation (50-60%) and plant parts and/or extracts of the plant (40-50%) selected from the group consisting of | 01-26-2012 |
Ghularn Nabi Qazi, Jammu Tawi IN
| Patent application number | Description | Published |
|---|---|---|
| 20110201661 | Spiro Derivatives of Parthenin as Novel Anticancer Agents - The present invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides, nitrones, azides, nitrile ylide diazoalkane, nitrile imide, ozone, azomethine imides, azomethine ylides etc. with exocyclic double bond of C ring (α-methylene-γ-butyrolactone). Representative compounds have been screened for their anticancer activity against different cancer cell lines. ICs0 value of these analogues varies between 4.3 μM to 93 μM. A mechanistic correlation of their anticancer activity has been described. The results of the cytotoxicity test of the compounds studies indicated that the α,β-unsaturated ketonic moiety in parthenin plays an important role in the maintenance of the high level of cytotoxicity. | 08-18-2011 |
Maleeha Qazi, King Of Prussia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090106238 | Contextual Searching of Electronic Records and Visual Rule Construction - A web-based system for visual construction of logical rules includes a server, a network, and client operatively connected to the server via the network. The server includes a database and a search engine. The client includes a web-based visual rule building application including selectable windows for displaying and visually editing terms, logical operators, logical rules for storage in the database. The logical rules are generated by visually selecting at least one of the terms and logical operators from the windows. The server may further include a search engine configured to perform at least one of a direct search or a contextual search for an entered query string in records stored in the database and the client may include a visual interface for displaying results of the searches. The search results generated by the search engine may be stored as terms in the database for subsequent rule generation. | 04-23-2009 |
| 20100049756 | Medical Intelligence Framework - A framework executing on a computational structure and supporting a plurality of simultaneously executing software applications with a shared layer, wherein the framework is disposed between the plurality of applications and a set of data sources, the framework decomposing, processing, and analyzing data passed between the plurality of applications and the data sources into information elements. | 02-25-2010 |
Muhammad Qazi, Columbia, SC US
| Patent application number | Description | Published |
|---|---|---|
| 20100173422 | METHOD OF SENSING CHEMICAL AND BIO-MOLECULAR ANALYTES AND SENSING SYSTEM USING A MICROCANTILEVER - Methods and systems of detecting analytes using a microcantilever system are generally described. The microcantilever system generally includes micro- or nano-sized elements that can be electrostatically driven to resonance. Utilizing the disclosed devices and methods, direct electronic detection of the resonant frequency, changes of the resonant frequency, and associated phase signal of a micro- or nano-sized element can be utilized to measure the presence of a targeted analyte. The detection system of the present invention utilizes a non-contact microcantilever device. That is, the surface of the microcantilever (e.g., the surface of the resonating beam) does not bond or otherwise attach to an analyte or other chemical. Thus, the microcantilever device, including the resonating beam, can be kept in pristine condition during and even after repeated use. | 07-08-2010 |
Muhammad Waseem Tahir Qazi, Richmond Hill CA
| Patent application number | Description | Published |
|---|---|---|
| 20090214657 | Orally Absorbed Pharmaceutical Formulation and Method of Administration - A pharmaceutical formulation for absorption through oral mucosae comprising an effective amount of (a) a pharmaceutical agent in mixed micellar form, (b) at least one micelle-forming compound selected from the group comprising an alkali metal alkyl sulfate and a polyoxyethylene sorbitan monooleate, (c) a block copolymer of polyoxyethylene and polyoxypropylene, (d) at least one additional micelle-forming compound, and (e) a suitable solvent. The invention also provides a metered dose dispenser (aerosol or non-aerosol) containing the present formulation and a method of administering insulin using the metered dose dispenser comprising administering split doses of a formulation containing insulin before and after each meal. | 08-27-2009 |
Muhammad W. T. Qazi, Richmond Hill CA
| Patent application number | Description | Published |
|---|---|---|
| 20090069437 | Compositions for Oral Transmucosal Delivery of Metformin - The invention relates to oral transmucosal pharmaceutical compositions comprising metformin or a pharmaceutically acceptable salt thereof, methods of using the compositions to treat various conditions, including diabetes, methods of preparing the compositions, and preparations for use in making the compositions. | 03-12-2009 |
Naveed Ahmed Qazi, Jammu Tawi IN
| Patent application number | Description | Published |
|---|---|---|
| 20110201661 | Spiro Derivatives of Parthenin as Novel Anticancer Agents - The present invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides, nitrones, azides, nitrile ylide diazoalkane, nitrile imide, ozone, azomethine imides, azomethine ylides etc. with exocyclic double bond of C ring (α-methylene-γ-butyrolactone). Representative compounds have been screened for their anticancer activity against different cancer cell lines. ICs0 value of these analogues varies between 4.3 μM to 93 μM. A mechanistic correlation of their anticancer activity has been described. The results of the cytotoxicity test of the compounds studies indicated that the α,β-unsaturated ketonic moiety in parthenin plays an important role in the maintenance of the high level of cytotoxicity. | 08-18-2011 |